BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Prionics AG Acquires Pfizer Animal Health's Diagnostic Products


10/24/2005 10:35:31 AM

ZURICH, Switzerland, October 24 /PRNewswire/ --

- Promising Products for the Swiss Success Company

Prionics AG, the world leader in prion diagnostics and Pfizer Animal Health, the world's leading animal health company, agreed today that Prionics will acquire Pfizer Animal Health's diagnostic products. Terms were not disclosed.

The product line includes tests for the detection of Bovine tuberculosis (Bovigam(R)) and Paratuberculosis (Parachek(R)) in animals raised as a food source. Both diseases cause major economic damage to the farm industry and also have implications to human health.

Bovigam(R) and Parachek(R) are among the leading products in their field with significant shares in existing markets and an attractive potential for the development of new markets. "With this expansion of our product portfolio, we are confident that we're well positioned to further grow sustainably in the farm animal diagnostics business", says Ernst Zollinger, Head of Marketing & Sales at Prionics.

Prionics will fully integrate the diagnostic tests into its product portfolio through a one year transition phase to ensure a smooth changeover. "We are confident, that our new clients will profit from Prionics' specialized customer service. We will contact these customers directly to inform them about the planned steps", explains Zollinger. "Moreover, we intend to use our innovative development know-how to further improve the two tests in order to offer our clients even better solutions."

Tuberculosis and Paratuberculosis

Bovine tuberculosis and Paratuberculosis are major farm animal diseases that cause severe economic damage in breeding stock, milk and meat producing animals worldwide with severe implications to human health. Diagnostic tests for Bovine tuberculosis and Paratuberculosis can help to reduce the risk of infection in humans as well as contribute to targeted eradication and control of these diseases.

Bovine tuberculosis (TB) is an infectious disease that is caused by the bacteria Mycobacterium bovis (M. bovis). Bovine TB primarily affects cattle, however, other animals may become infected. Disease due to M. bovis in animals most often occurs in the lungs but may also occur in the intestines and other parts of the body. M. bovis is transmitted to humans primarily through consumption of raw milk or dairy products but can also be transmitted through the respiratory route.

Paratuberculosis leads to Johne's Disease in cattle, goat and wild animals and has been implicated as a causal agent for Crohn's Disease in humans - a chronic inflammatory bowel disease.

About Prionics

The world market leader for rapid prion testing was founded in 1997 as a spin-off from the University of Zurich. Prionics carries out research and development in diagnostics for prion diseases (such as BSE) and other zoonotic diseases. The recipient of the Swiss Economic Award 2002 as "Company of the year" and winner of the European Biotech Award 2004 for Excellence in Biotech Business is driving its business through a combination of outstanding research, high-quality products and new marketing concepts.

For more information please visit www.prionics.com or contact:

Stephanie Musshafen; Director of Corporate Communications; tel. : +41-44-200-20-95 ; e-mail : press.relations@prionics.ch

Prionics AG

CONTACT: Stephanie Musshafen; Director of Corporate Communications; tel. :+41-44-200-20-95 ; e-mail : press.relations@prionics.ch



Read at BioSpace.com
Read at Canada NewsWire
Read at The Street.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES